TOOTH TINCTURE (MENOFRESH)

Indications

• Topical analgesic for pain relief
• Anti-inflammatory agent
• Antimicrobial treatment for skin infections
• Wound healing promoter
• Aromatherapy for respiratory conditions

Dosage

Children: Refer to specific product guidelines for dosing, as it can vary widely and should be adjusted based on the child's age, weight, and condition.

Adults: Refer to specific product guidelines for dosing, as it can vary widely depending on formulation and intended use.

Mechanism of action

Balsam compounds may exert their effects through several mechanisms, including the modulation of inflammatory pathways, acting as antioxidants, and possessing antimicrobial properties. Specific balsams may contain active components like resins, essential oils, and other phytochemicals that interact with cellular signaling pathways, leading to reduced inflammation and pain, as well as inhibition of microbial growth.

Pharmacodynamics

The pharmacodynamics of balsams can vary depending on the specific type and its constituents. Generally, they can enhance local blood flow, promote wound healing, and provide symptomatic relief from pain and inflammation. Their antimicrobial action helps prevent infections in wounds or skin irritations. Balsams may also stimulate the immune system and have a soothing effect on mucous membranes.

Pharmacokinetics

Pharmacokinetics of balsams largely depend on their formulation and route of administration. When applied topically, absorption can occur through the skin, leading to local therapeutic effects. Systemic absorption is generally low, but some components may enter circulation. Metabolism occurs mainly in the liver, with excretion through urine. The onset of action can be relatively rapid for topical applications, while systemic effects may take longer depending on dose and route.

Pregnancy

The safety of balsam during pregnancy has not been established. Use only if clearly needed and the benefits outweigh the risks.

Breast-feeding

It is not known whether balsam is excreted in human milk. Caution should be exercised when administered to breastfeeding women.

Storage

Store in a cool, dry place away from direct light. Keep out of reach of children.

Indications

• Respiratory infections
• Muscle pain
• Joint pain
• Inflammation
• Cough

Dosage

Children: In children, the use of cajuput oil should be approached with caution and under the guidance of a healthcare professional. Dilution and appropriate application methods should be considered. Refer to specific guidelines for precise dosing.

Adults: For topical application, cajuput oil can be diluted with a carrier oil and applied to the affected area or used in steam inhalation for respiratory relief. Refer to specific guidelines for precise dosing.

Mechanism of action

Cajuput oil contains compounds such as 1,8-cineole and alpha-terpineol, which exert their effects primarily through anti-inflammatory and analgesic pathways. These compounds may inhibit the synthesis of pro-inflammatory cytokines and modulate pain pathways, contributing to its therapeutic effects. Additionally, the oil acts as a mucolytic agent, helping to clear mucus from the respiratory tract.

Pharmacodynamics

Cajuput oil exhibits a range of pharmacodynamic properties, including antimicrobial activity against various pathogens, making it effective in treating infections. Its anti-inflammatory effects contribute to pain relief and reduction of swelling, while its expectorant properties facilitate the expulsion of mucus, alleviating symptoms of respiratory conditions.

Pharmacokinetics

The pharmacokinetics of cajuput oil are characterized by its absorption through the skin and mucous membranes, leading to a rapid onset of action. The compounds are metabolized primarily in the liver, with various metabolites excreted via the kidneys. The half-life and specific metabolic pathways can vary based on the individual and the route of administration.

Adverse effects

• Skin irritation
• Allergic reactions
• Gastrointestinal disturbances

Precautions

• Use cautiously in individuals with sensitive skin
• Avoid contact with eyes and mucous membranes
• Not recommended for prolonged use

Pregnancy

Use during pregnancy should be approached with caution, as safety has not been established.

Breast-feeding

Consult a healthcare professional before use while breastfeeding.

Storage

Store in a cool, dry place, away from direct sunlight.

Formulations

• Essential oil
• Topical preparations

Indications

• Pain relief
• Anti-inflammatory conditions
• Antimicrobial applications
• Dental pain
• Digestive disorders

Dosage

Children: Refer to healthcare professional for appropriate dosing guidelines as clove oil is generally not recommended for children without medical supervision.

Adults: For topical application, clove oil can be diluted with a carrier oil and applied as needed. For oral use, standard culinary doses are generally considered safe, but specific therapeutic doses should be guided by a healthcare professional.

Mechanism of action

Eugenol, the primary active compound in clove, exhibits its effects through several pathways. It acts as an analgesic by inhibiting the synthesis of prostaglandins, which are mediators of pain and inflammation. Additionally, eugenol has been shown to interact with voltage-gated sodium channels, which may contribute to its analgesic effects. Its antimicrobial properties are partly due to its ability to disrupt the cell membranes of bacteria and fungi.

Pharmacodynamics

Clove has a variety of pharmacodynamic effects, primarily attributed to eugenol. It exhibits analgesic, anti-inflammatory, and antioxidant properties. Clove oil has been found to reduce pain and inflammation in various experimental models. Its antimicrobial activity is effective against a range of pathogens, making it a candidate for use in oral health products. Furthermore, the antioxidant properties help in neutralizing free radicals, thereby providing protective effects against cellular damage.

Pharmacokinetics

Clove oil is absorbed through the gastrointestinal tract when ingested and can also be absorbed through the skin when applied topically. The bioavailability of eugenol can be influenced by its formulation and method of administration. Once absorbed, eugenol is distributed throughout the body, metabolized primarily in the liver, and excreted via the kidneys. The half-life of eugenol varies but is generally short, necessitating frequent dosing for sustained effects in therapeutic use.

Adverse effects

• Allergic reactions
• Gastrointestinal irritation
• Liver toxicity with excessive use
• Hypoglycemia

Interactions

• May enhance the effects of anticoagulants
• May interact with antidiabetic medications
• May reduce the effectiveness of certain antiepileptic drugs

Precautions

• Use with caution in individuals with liver disease
• Caution in patients with bleeding disorders
• Monitor blood sugar levels in diabetics

Pregnancy

Use during pregnancy is not recommended due to potential effects on the fetus.

Breast-feeding

Limited data available; use with caution as clove can affect milk production.

Storage

Store in a cool, dry place away from direct sunlight.

Formulations

• Essential oil
• Dried whole cloves
• Powdered clove

Indications

• Topical analgesic for muscle and joint pain
• Cough suppressant in cough drops and lozenges
• Relief of minor throat irritation
• Cooling agent in various cosmetic and personal care products

Dosage

Children: Refer to BNF for Children for specific dosing guidelines, as doses may vary based on age and formulation.

Adults: For topical use, apply a thin layer to the affected area not more than 3 to 4 times daily. For cough drops, follow the product-specific instructions as per the formulation.

Mechanism of action

Menthol acts as an agonist for the transient receptor potential subtype M8 (TRPM8), a non-selective cation channel that is activated by cold temperatures. This activation leads to calcium influx in mast cells, inducing the release of histamine, which can trigger allergic responses such as urticaria, asthma, and rhinitis. Menthol's ability to induce histamine release via TRPM8 suggests potential therapeutic applications for TRPM8 antagonists in managing cold- and menthol-induced allergies.

Pharmacodynamics

Menthol produces a cooling effect by stimulating sensory neurons that convey cold sensations. It interacts with TRPM8 channels, leading to the activation of intracellular signaling pathways that can result in vasodilation and increased blood flow to the area of application. This cooling sensation can provide symptomatic relief in conditions characterized by pain or irritation.

Pharmacokinetics

Menthol is absorbed through the skin and mucous membranes, with systemic effects depending on the route of administration. Its bioavailability can vary, and it is metabolized primarily in the liver. The elimination half-life and excretion pathways have not been extensively characterized, but menthol is generally considered to have a rapid onset of action with effects lasting for a few hours.

Adverse effects

• Allergic reactions
• Urticaria
• Asthma
• Rhinitis
• Skin irritation

Precautions

• Use with caution in patients with known allergies to menthol or related compounds
• May exacerbate asthma in sensitive individuals

Pregnancy

There are no well-controlled studies of menthol in pregnant women. Menthol should be used during pregnancy only if clearly needed.

Breast-feeding

Menthol is excreted in breast milk. Caution should be exercised when administering to nursing mothers.

Storage

Store in a cool, dry place away from light. Keep out of reach of children.

Formulations

• Topical ointment
• Cream
• Liquid

Dosage

Children: There are no established therapeutic doses for toluene in the pediatric population. Exposure should be avoided due to potential toxicity.

Adults: There are no established therapeutic doses for toluene as it is primarily used as an industrial solvent. Exposure should be minimized due to its toxic effects.

Mechanism of action

Toluene exerts its effects primarily through its interaction with the central nervous system. It acts as a neurotoxin and can influence neurotransmitter systems, particularly those involving gamma-aminobutyric acid (GABA) and glutamate. The exact pathways are not fully elucidated, but toluene is known to enhance GABAergic activity, leading to sedative and anxiolytic effects, while also disrupting glutamate signaling, which can contribute to neurotoxicity.

Pharmacodynamics

The pharmacodynamics of toluene involve its effects on the central nervous system, where it can lead to a range of symptoms from euphoria and intoxication to neurological impairment and respiratory depression at higher exposures. Chronic exposure may result in neurobehavioral deficits, cognitive dysfunction, and potential long-term neurological damage. The effects can vary significantly based on concentration, duration of exposure, and individual susceptibility.

Pharmacokinetics

Toluene is rapidly absorbed through inhalation and dermal routes, with peak blood concentrations occurring shortly after exposure. It is metabolized primarily in the liver via cytochrome P450 enzymes, leading to the formation of various metabolites, including benzyl alcohol and hippuric acid. These metabolites are excreted in the urine. The elimination half-life of toluene varies depending on the route of exposure and individual metabolic factors, generally ranging from a few hours to a day.

Pregnancy

Toluene is not recommended during pregnancy due to potential risks to fetal development. It may cause teratogenic effects.

Breast-feeding

Toluene may be excreted in breast milk, and its use is generally not recommended while breastfeeding due to potential harm to the nursing infant.

Storage

Store in a cool, dry place away from direct sunlight, heat, and ignition sources. Ensure containers are tightly sealed.

Mechanism of action

Exposure to low temperatures often causes allergic responses or urticaria. Similarly, menthol, a common food additive is also known to cause urticaria, asthma, and rhinitis. However, despite the obvious clinical implications, the molecular mechanisms responsible for inducing allergic responses to low temperatures and menthol have not been determined. Because a non-selective cation channel, transient receptor potential subtype M8 (TRPM8) is activated by cold and menthol, we hypothesized that this channel mediates cold- and menthol-induced histamine release in mast cells. Here, we report that TRPM8 is expressed in the basophilic leukemia mast cell line, RBL-2H3, and that exposure to menthol or low temperatures induced Ca(2+) influx in RBL-2H3 cells, which was reversed by a TRPM8 blocker. Furthermore, menthol, a TRPM8 agonist, induced the dose-dependent release of histamine from RBL-2H3 cells. When TRPM8 transcripts were reduced by siRNA (small interfering RNA), menthol- and cold-induced Ca(2+) influx and histamine release were significantly reduced. In addition, subcutaneous injection of menthol evoked scratching, a typical histamine-induced response which was reversed by a TRPM8 blocker. Thus, our findings indicate that TRPM8 mediates the menthol- and cold-induced allergic responses of mast cells, and suggest that TRPM8 antagonists be viewed as potential treatments for cold- and menthol-induced allergies. /DL-Menthol/ Menthol's characteristic cooling sensation is due, in part, to the activation of sensory neurons generally termed transient receptor potential (TRP) channels, in particular transient receptor potential melastatin family member 8 (TRPM8) and transient receptor potential subfamily A, member 1 (TRPA1). Menthol acts upon TRPM8 receptors by rapidly increasing intracellular calcium and mobilizing calcium flux through the channels to induce cold response signals at the application site. Aside from its cold-inducing sensation capabilities, menthol exhibits cytotoxic effects in cancer cells, induces reduction in malignant cell growth, and engages in synergistic excitation of GABA receptors and sodium ion channels resulting in analgesia. /DL-Menthol/ In recent years, the transient receptor potential melastatin member 8 (TRPM8) channel has emerged as a promising prognostic marker and putative therapeutic target in prostate cancer. We have found that forced overexpression of TRPM8 in PC-3 cells can inhibit the cell proliferation and motility probably through the TRPM8 activation. In this study, we aimed to investigate whether activating the TRPM8 channel by its selective agonist menthol can inhibit the proliferation and motility of androgen-independent prostate cancer (AIPC) with remarkable expression of TRPM8. Menthol is a naturally occurring compound, which has been widely used in cosmetics and pharmaceutical products, and also as flavoring in food. DU145 cells are androgen-independent but have a remarkable expression of TRPM8. The demonstration of the existence of TRPM8 and the absence of TRPA1 in DU145 cells provided the foundation for the following experiments, because both TRPM8 and TRPA1 are molecular targets of menthol. The outcome of MTT assay indicated that menthol inhibited the cell growth (p < 0.01). Cell cycle distribution and scratch assay analysis revealed that menthol induced cell cycle arrest at the G(0)/G(1) phase (p < 0.01). Furthermore, menthol inhibited the migration of DU145 cells by downregulating the focal-adhesion kinase. So it suggests that the activation of the existing TRPM8 channels may serve as a potential and pragmatic treatment for those AIPC with remarkable expression of TRPM8, and menthol is a useful compound for future development as an anticancer agent. /DL-Menthol/